Natera Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Good afternoon, everybody. I'm Tycho Peterson from the Life Science team. It's my pleasure to introduce our next company this afternoon, Natera. Just a quick reminder, if you've got questions, you could submit them through the function on the website. With that, let me turn it over to Steve.
Great. Thanks, Tycho. Appreciate you having us today. So I want to start off just briefly on Slide #2, our safe harbor statement. I just recommend you to take a look at this. It's on our website. Feel free to read through that.
Slide #3, a little bit on the background of Natera first. So Natera is today the leader in cell-free DNA technology. In 2013, we had the launch of our product in the field of women's health, Panorama NIPT. And the product is based on proprietary molecular biology techniques combined with unique bioinformatic algorithms that allow us to get down to the level of a single molecule in a tube of blood
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
